Skip to main content
SpringerLink
Log in

Effects of bisoprolol on left ventricular hypertrophy in essential hypertension

  • Hypertension
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Previous studies have shown that beta-adrenergic blocking drugs can reverse ventricular hypertrophy in patients with systemic hypertension. Thirty patients with essential hypertension and left ventricular hypertrophy were studied at baseline after withdrawing all previous treatments and after 6 months of treatment with 5–20 mg of bisoprolol, a new beta-selective agent, to assess its possible action on left ventricular mass. Three patients did not finish the study. Blood pressure was reduced to below 160/90 mmHg in 22 of the remaining 27 patients. At the end of follow-up, the left ventricular mass (echocardiography) was reduced from 308.1±89 g to 262.3±51 g (p<0.001) and left ventricular mass index from 165±47.4 g/m2 to 141.03±26.7 g/m2 (p<0.001). The ratio of E wave/A wave velocity of transmitral blood flow measured by Doppler increased from 0.86±0.44 to 1.07±0.45 (p=0.005). Peak filling rate, derived from nuclear ventriculography, changed from 2.05±0.4 EDV/sec before the treatment to 2.23±0.47 EDV/sec after it (p=0.0046). Serum lipids as well as other biochemical tests were unchanged. Left ventricular volumes and ejection fraction did not change, and treadmill exercise time increased from 343±125 seconds to 420±135 seconds (p=0.002). Maximal systolic blood pressure during exercise decreased from 197.2±19.7 mmHg to 182.9±25.8 mmHg (p=0.011). There were few side effects. We conclude that bisoprolol reduces left ventricular mass, preserves systolic function, and improves diastolic function of the left ventricle in hypertensive subjects with left ventricular hypertrophy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Strauer BE. Structural and functional adaptation of the chronically overloaded heart in arterial hypertension.Am Heart J 1987;114:948–957.

    PubMed  Google Scholar 

  2. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study.Am J Cardiol 1987;59:956–960.

    PubMed  Google Scholar 

  3. Levy D, Garrison RJ, Savage DD, Kanel WB, Castelli WP. Prognosis implications of echocardiographically determined left ventricular mass in the Framingham study.N Engl J Med 1990;322:1561–1569.

    PubMed  Google Scholar 

  4. McLenahan JM, Henderson E, Morris KI, Dargie HG. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy.N Engl J Med 1987;317:787–792.

    PubMed  Google Scholar 

  5. Kannel WB, Schatzkin A. Sudden death: Lessons from subsets in population studies.J Am Coll Cardiol 1985;5(Suppl 6):141B-149B.

    PubMed  Google Scholar 

  6. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure: The Framingham Study.N Engl J Med 1972:287:781–787.

    PubMed  Google Scholar 

  7. MacMahon SW, Wilcken DEL, MacDonald GJ. The effect of weight reduction on left ventricular mass: A randomized, controlled trial in young overweight hypertensive patients.N Engl J Med 1986;314:334–339.

    PubMed  Google Scholar 

  8. Liebson PR. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy.Am J Hypertens 1990;3:512–517.

    PubMed  Google Scholar 

  9. Tarazi RC. Regression of left ventricular hypertrophy by medical treatment: Present status and possible implications. In: Messerli FH, ed.The Heart and Hypertension. New York: Yorke Medical Books, 1987:287–298.

    Google Scholar 

  10. Trimarco B, DeLuca N, Ricciardelli B, et al. Cardiac function in systemic hypertension before and after reversal of left ventricular hypertrophy.Am J Cardiol 1988;62:745–750.

    PubMed  Google Scholar 

  11. Schulman SP, Weiss JL, Becker LC, et al. The effects of antihypertensive therapy on left ventricular mass in elderly patients.N Engl J Med 1990;322:1350–1356.

    PubMed  Google Scholar 

  12. Messerli FH, Nunez MM, Garavaglia GG, Schiemer RE, Ventura HO. Hypertension and sudden death: Disparate effects of calcium entry blockers and diuretic therapy on cardiac dysrhythmias.Arch Intern Med 1989;149:1263–1267.

    PubMed  Google Scholar 

  13. Trimarco B, DeLuca N, Cuocolo A, et al. Beta blockers and left ventricular hypertrophy in hypertension.Am Heart J 1987;114:975–983.

    PubMed  Google Scholar 

  14. Prichard BNC. Bisoprolol: A new beta-adrenoceptor blocking drug.Eur Heart J 1987;8(Suppl M):121–129.

    Google Scholar 

  15. Lithell H, Selinus I, Hosie J, Frithz G, Weiner L. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: A double-blind, parallel group international multicentre study.Eur Heart J 1987;8(Suppl M):55–64.

    Google Scholar 

  16. Amabile G, Serradimigni A. Comparison of bisoprolol with nifedipine for treatment of essential hypertension in the elderly: Comparative double-blind trial.Eur Heart J 1987;8(Suppl M):65–69.

    Google Scholar 

  17. Devereux RB, Lutas EM, Casale PN, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements.J Am Coll Cardiol 1984;4:1222.

    PubMed  Google Scholar 

  18. Devereux RB, Reichek N. Electrocardiographic determination of left ventricular mass in man: Anatomic validation of the method.Circulation 1977;55:613–618.

    PubMed  Google Scholar 

  19. Clements IP, Sinak LJ, Gibbons RJ, Brown ML, O'Connor MK. Determination of diastolic function by radionuclide ventriculography.Mayo Clin Proc 1990;65:1007–1019.

    PubMed  Google Scholar 

  20. Frithz G, Weiner L. Long-term effect of bisoprolol on blood pressure, serum lipids and HDL-cholesterol in patients with essential hypertension.J Cardiovasc Pharmacol 1986;8(Suppl 11):134–138.

    Google Scholar 

  21. Bühler FR, Berglund G, Anderson OK, et al. Double-blind comparison of the cardioselective β-blockers bisoprolol and atenolol in hypertension: The Bisoprolol International Multicenter Study (BIMS).J Cardiovasc Pharmacol 1986;8(Suppl 11):122–127.

    Google Scholar 

  22. Lithell H, Weiner L, Selinus I, Vessby B. A comparison of the effect of bisoprolol and atenolol on lipoprotein concentrations and blood pressure.J Cardiovasc Pharmacol 1986;8(Suppl 11):128–133.

    Google Scholar 

  23. Gosse P, Roudaut R, Herrero G, Dallocchio M. β-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: Effects on left ventricular hypertrophy.J Cardiovasc Pharmacol 1990;16(Suppl 5):S145-S150.

    PubMed  Google Scholar 

  24. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies.Am J Hypertens 1992;5:95–110.

    PubMed  Google Scholar 

  25. Weber KT, Brilla CG, Campbell SE. Regulatory mechanisms of myocardial hypertrophy and fibrosis: Results of in vivo studies.Cardiology 1992;81:266–273.

    PubMed  Google Scholar 

  26. Devereux RB, Savage DD, Sachs I, Laragh JH. Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension.Am J Cardiol 1983;51:171–176.

    PubMed  Google Scholar 

  27. Frohlich ED. Cardiac hypertrophy in hypertension.N Engl J Med 1987;317:831–833.

    PubMed  Google Scholar 

  28. Fouad-Tarazi FM. Ventricular diastolic function of the heart in systemic hypertension.Am J Cardiol 1990;65:85G-88G.

    PubMed  Google Scholar 

  29. White WB, Schulman P, Karimeddini MK, Smith V-E. Regression of left ventricular mass is accompanied by improvement in rapid left ventricular filling following antihypertensive therapy with metoprolol.Am Heart J 1989;117:145–150.

    PubMed  Google Scholar 

  30. Trimarco B, de Luca N, Rosiello G, et al. Improvement of diastolic function after reversal of left ventricular hypertrophy induced by long-term antihypertensive treatment with tertatolol.Am J Cardiol 1989;64:745–751.

    PubMed  Google Scholar 

  31. Clozel JP, Kuhn H, Hefti D. Decrease of vascular hypertrophy in four different types of arteries in spontaneously hypertensive rats.Am J Med 1989;87(Suppl 6B):92S-95S.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Clinica Puerto de Hierro, Madrid, Spain

    Eduardo de Teresa, Magdalena González, Crescencio Camacho-Vázquez & Ma José Tabuenca

Authors
  1. Eduardo de Teresa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Magdalena González
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Crescencio Camacho-Vázquez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ma José Tabuenca
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Teresa, E., González, M., Camacho-Vázquez, C. et al. Effects of bisoprolol on left ventricular hypertrophy in essential hypertension. Cardiovasc Drug Ther 8, 837–843 (1994). https://doi.org/10.1007/BF00877402

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00877402

Key Words

Search

Navigation